药效评价Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior.
期刊:Pharmacology, biochemistry, and behavior发表年份:2006作者:Craig F Ferris; Shi-Fang Lu; Tara Messenger; Christophe D Guillon; Ned Heindel; Marvin Miller; Gary Koppel; F Robert Bruns; Neal G Simon
